Share Email Print

Journal of Biomedical Optics

In situ measurements of brain tissue hemoglobin saturation and blood volume by reflectance spectrophotometry in the visible spectrum
Author(s): Joseph C. LaManna
Format Member Price Non-Member Price
PDF $20.00 $25.00

Paper Abstract

Before the development of near-infrared spectroscopy (NIRS) for monitoring of hemoglobin and cytochromes in situ, the Jöbsis laboratory designed a visible light reflectance spectrophotometer. The method was not as useful for cytochrome oxidase measurements, which stimulated the search for a better method that culminated in NIRS. Visible light reflectance spectrophotomery was, however, usefully applied in several experimental applications, such as the study of brain capillary hemoglobin saturation during changes in inspired gas mixtures in awake and anesthetized animals, and to record transient increases in total hemoglobin (blood volume) after local neuronal activation by direct cortical electrical stimulation, demonstrating a response that is fundamental to functional magnetic resonance imaging blood oxygen level–dependent methods. A third application of the instrumentation was for brain capillary red cell mean transit time analysis, estimated by recording the passage of a red cell–free bolus through the cerebral cortical optical monitoring field. Taken together with his previous application of fluorescence detection of nicotinamide adenine dinucleotide, the visible and near-infrared spectroscopy demonstrate that Frans Jöbsis was a pioneer in the application of optical techniques to the study of intact organs in situ. These methods have been used to illuminate the basic function of the cerebrovascular and metabolic pathways in both physiological and pathological conditions.

Paper Details

Date Published: 1 November 2007
PDF: 5 pages
J. Biomed. Opt. 12(6) 062103 doi: 10.1117/1.2804184
Published in: Journal of Biomedical Optics Volume 12, Issue 6
Show Author Affiliations
Joseph C. LaManna, Case Western Reserve Univ. (United States)

© SPIE. Terms of Use
Back to Top